Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 5:13:1124101.
doi: 10.3389/fonc.2023.1124101. eCollection 2023.

Incidence, mortality and survival trends of penile cancer in Lithuania 1998-2017

Mingaile Drevinskaite  1 , Ausvydas Patasius  1   2 , Marius Kincius  3 , Justinas Jonušas  1   4 , Adomas Ladukas  1 , Mindaugas Jievaltas  5 , Laura Kairevice  6 , Giedre Smailyte  1   2
Affiliations

Incidence, mortality and survival trends of penile cancer in Lithuania 1998-2017

Mingaile Drevinskaite et al. Front Oncol. .

Abstract

Background and objectives: The aim of this study was to analyse trends in penile cancer incidence, mortality, and relative survival in Lithuania during the period of 1998-2017.

Materials and methods: The study was based on all cases of penile cancer reported to the Lithuanian Cancer Registry between 1998 and 2017. Age-specific rates standardized rates were calculated, using the direct method (World standard population). The Joinpoint regression model was used to provide estimated average annual percentage change (AAPC). One-year and five-year relative survival estimates were calculated using period analysis. Relative survival was calculated as the ratio of the observed survival of cancer patients and the expected survival of the underlying general population.

Results: During the study period, the age-standardized incidence rate of penile cancer varied between 0.72 and 1.64 per 100 000, with AAPC 0.9% (95% CI -0.8-2.7). The mortality rate of penile cancer in Lithuania during this period varied from 0.18 to 0.69 per 100 000, with AAPC of -2.6% (95% CI -5.3-0.3). Relative one-year survival of patients, diagnosed with penile cancer improved over the time from 75.84% in period 1998-2001 to 89.33% in period 2014-2017. Relative five-year survival rate of patients, diagnosed with penile cancer changed from 55.44% in period 1998-2001 to 72.90% in period 2014-2017.

Conclusions: The incidence rates of penile cancer showed an increasing trend, while mortality rates were decreasing in Lithuania during 1998-2017. One-year and five-year relative survival increased, however, it does not reach the highest scores of Northern European countries.

Keywords: cancer; epidemiology; incidence; mortality; penile; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Age-specific incidence and mortality rates of penile cancer in Lithuania in 1998–2017.
Figure 2
Figure 2
Age-standardized incidence and mortality trends of penile cancer in Lithuania in 1998–2017.
Figure 3
Figure 3
Relative one-year and five-year survival of penile cancer patients in Lithuania by period of diagnosis.
See this image and copyright information in PMC

References

    1. Thomas A, Necchi A, Muneer A, Tobias-Machado M, Tran ATH, Van Rompuy AS, et al. . Penile cancer. Nat Rev Dis Primers (2021) 7(1):11. doi: 10.1038/s41572-021-00246-5 - DOI - PubMed
    1. Montes Cardona CE, García-Perdomo HA. Incidence of penile cancer worldwide: systematic review and meta-analysis. Rev Panam Salud Publica (2017) 41:e117. doi: 10.26633/RPSP.2017.117 - DOI - PMC - PubMed
    1. Fu L, Tian T, Yao K, Chen XF, Luo G, Gao Y, et al. . Global pattern and trends in penile cancer incidence: population-based study. JMIR Public Health Surveill (2022) 8(7):e34874. doi: 10.2196/34874 - DOI - PMC - PubMed
    1. Moch H, Amin MB, Berney DM, Compérat EM, Gill AJ, Hartmann A, et al. . The 2022 world health organization classification of tumours of the urinary system and Male genital organs–part a: renal, penile, and testicular tumours. Eur Urol (2022) 82(5):458-68. doi: 10.1016/j.eururo.2022.06.016 - DOI - PubMed
    1. Olesen TB, Sand FL, Rasmussen CL, Albieri V, Toft BG, Norrild B, et al. . Prevalence of human papillomavirus DNA and p16INK4a in penile cancer and penile intraepithelial neoplasia: a systematic review and meta-analysis. Lancet Oncol (2019) 20(1):145–58. doi: 10.1016/S1470-2045(18)30682-X - DOI - PubMed

LinkOut - more resources